Back to All

Photobiomodulation for Oral Mucositis

Presented by: James Carroll

Original Presentation Date: September 24, 2021

Take the Course This course is available for CE Credit as a "Members Only" benefit. Not a Member? CLICK HERE to learn more about AAOSH Membership.

Course Description:

Join James Carroll, CEO and Founder of THOR, for an enlightening course on photobiomodulation. You'll start by building a strong foundation in its core concepts and understanding its principles. Then, you'll delve into the practical aspects, comprehensively explaining how it works and its essential procedures. Explore its various applications in dentistry and examine its role in managing oral mucositis. Finally, discover a wide range of oral uses for photobiomodulation. This course will equip you with a deep understanding of this innovative approach in dental practice.

Learning Objectives:

  • Introduce the concept of photobiomodulation, demonstrating a grasp of its fundamental principles.
  • Explain the mechanisms and procedures of applying photobiomodulation, illustrating a comprehensive understanding of its functions.
  • Explore and delineate various applications of photobiomodulation within the field of dentistry, demonstrating the ability to examine its diverse uses critically.
  • Examine the specific role of photobiomodulation in treating oral mucositis, dissecting its significance in managing this condition.
  • Introduce diverse applications and oral uses for photobiomodulation, showcasing a broader comprehension of its potential in dentistry.

Speaker Bio:

James Carroll is the Founder and CEO of THOR Photomedicine, co-authored 27 academic photobiomodulation (PBM) papers, and contributed chapters to five photobiomodulation books. James is a recognized authority on PBM dose, dose-rate effects, and the measurement and reporting of parameters. He is the Co-Chair of the Biomedical Optics Society conference on photobiomodulation mechanisms, a Fellow of The Royal Society of Medicine, and a World Association for Photobiomodulation Therapy (WALT) Committee member.